Search - tctmd.com

Displaying 721 - 740 of 891

Sort: Relevancy | Date

News Conference News TCT 2014

Affordable Care Act-Related Changes Hold Promise for Future of Device Innovation, Physician Payments

September 16, 2014

Presentation TCT 2014

TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure

Presenter: Howard C. Herrmann, Spencer H. Kubo, Sami Alnasser

September 15, 2014

Presentation TCT 2014

Coronary Arteriovenous Fistulae: Assessment and Interventional Decisions

Presenter: Ziyad M. Hijazi, John F. Rhodes, Elchanan Bruckheimer

September 15, 2014

Presentation TCT 2014

Case #4: Hemodynamic Support Decisions in Cardiogenic Shock

Presenter: Emmanouil S. Brilakis, Jose P.S. Henriques, Stefan K. James, Keith G. Oldroyd, Thomas D. Stuckey, William W. O'Neill

September 15, 2014

Presentation TCT 2014

Forget Hybrid Do the Whole Thing Robotically!

Presenter: Ajay J. Kirtane, David Taggart, Michael DECEASED J. Davidson

September 15, 2014

News Conference News TCT 2014

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Conference News TCT 2014

MOC Program Continues to Stir Controversy, Elicit Debate

September 15, 2014

News Conference News TCT 2014

Experts Disagree Over Endovascular Therapy for Acute Stroke

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Conference News TCT 2014

AUC ‘Here to Stay’ but Should Evolve, Expert Says

September 15, 2014

News Conference News TCT 2014

ACDs Modestly Reduce Access Site Complications, Major Bleeding

September 15, 2014

Presentation TCT 2014

Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Frederick Feit

September 14, 2014

Presentation TCT 2014

Physiology Changing Clinical Decision Making: Systematic Use of FFR From the French National Registry Study

Presenter: Javier Escaned, Nico H.J. Pijls, Morton J. Kern, Eric Van Belle

September 14, 2014

Presentation TCT 2014

Case #2 Results: What Was Done and How the Decision Was Made

Presenter: Julie Logan, Marian C. Hawkey, Ashish Pershad

September 14, 2014

Presentation TCT 2014

Case #1 Results: What Was Done and How the Decision Was Made

Presenter: Julie Logan, Marian C. Hawkey, James B. Hermiller Jr

September 14, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

Advertisement

Affordable Care Act-Related Changes Hold Promise for Future of Device Innovation, Physician Payments

TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure

Coronary Arteriovenous Fistulae: Assessment and Interventional Decisions

Case #4: Hemodynamic Support Decisions in Cardiogenic Shock

Forget Hybrid Do the Whole Thing Robotically!

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

MOC Program Continues to Stir Controversy, Elicit Debate

Experts Disagree Over Endovascular Therapy for Acute Stroke

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

AUC ‘Here to Stay’ but Should Evolve, Expert Says

ACDs Modestly Reduce Access Site Complications, Major Bleeding

Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)?

Physiology Changing Clinical Decision Making: Systematic Use of FFR From the French National Registry Study

Case #2 Results: What Was Done and How the Decision Was Made

Case #1 Results: What Was Done and How the Decision Was Made

TCT Course Director Outlines Current TAVR Controversies

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content